Rafferty Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
Other funds holding AGIO
Rafferty Asset Management's AGIO Position: Q3 2026 in Review
Rafferty Asset Management increased its Agios Pharmaceuticals (AGIO) stake by 33% in Q3 2026, buying an estimated $643K and bringing the position to 73,951 shares worth $2.46M. The position accounts for 0.01% of the portfolio, ranked #557.
Rafferty Asset Management first reported a position in AGIO in Q1 2019 and has held it in 31 quarters since. The position peaked at $6.47M in Q1 2024. 175 funds tracked by Wall St. Rank hold AGIO as of Q3 2026.
- Rafferty Asset Management held 73,951 shares of Agios Pharmaceuticals worth $2.46M as of Q3 2026.
- Rafferty Asset Management bought 18,371 Agios Pharmaceuticals shares in Q3 2026, an estimated $643K.
- Agios Pharmaceuticals made up 0.01% of Rafferty Asset Management's portfolio in Q3 2026, its #557 holding.
- Rafferty Asset Management first reported a position in Agios Pharmaceuticals in Q1 2019 and has held it in 31 quarters since.
- Rafferty Asset Management's Agios Pharmaceuticals position peaked at $6.47M in Q1 2024.
- 175 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2026.
Based on Rafferty Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.